The clinical evidence that α7 nAChR activation leads to improvement of cognitive dysfunction in schizophrenia still remains somewhat equivocal [100, 160], although the data for encenicline are encouraging [153, 161]. This evidence concerns the gene CHRNA7 and schizophrenia.